ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Improving patient outcomes in moderate-to-severe ulcerative colitis"
Episode Synopsis
touchEXPERT OPINIONS for touchIMMUNOLOGY
Listen to leading experts discuss important considerations in the optimal management of patients with moderate-to-severe ulcerative colitis.
The experts
Prof. Ailsa Hart – St Mark’s Hospital and Academic Institute, London, UK
Dr Gil Y Melmed – Inflammatory Bowel Disease Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA
Prof. Brian G Feagan – University of Western Ontario, London, ON, Canada
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent educational grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchimmunologyime.org/improving-outcomes-uc
Listen to leading experts discuss important considerations in the optimal management of patients with moderate-to-severe ulcerative colitis.
The experts
Prof. Ailsa Hart – St Mark’s Hospital and Academic Institute, London, UK
Dr Gil Y Melmed – Inflammatory Bowel Disease Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA
Prof. Brian G Feagan – University of Western Ontario, London, ON, Canada
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent educational grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchimmunologyime.org/improving-outcomes-uc
In God we trust